MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/jcma.0000000000001109

Медицинская библиотека · Journal of the Chinese Medical Association : JCMA · 2024

Body mass weighted prostate-specific antigen levels, new markers to predict locally advanced prostate cancer after prostatectomy.

Ou Ying-Lun, Yang Ming-Hsin, Kao Chien-Chang, Meng En, Chen Jin-Li, Tsao Chih-Wei, Sun Guang-Huan, Yu Dah-Shyong, Cha Tai-Lung, Wu Sheng-Tang

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Prostate-specific antigen (PSA) remains the most useful marker for screening, risk categorization, and follow-up in patients with prostate cancer. In the obese population, several studies have revealed that obesity may not only inversely interfere with the concentration of PSA, but also increase the risk of prostate cancer. Thus, we considered using the body mass weighted PSA levels, presented as serum PSA concentration multiplied by body weight or body mass index (BMI), instead of traditional PSA concentration, as potential markers to predict locally advanced prostate cancer after prostatectomy.

METHODS

We retrospectively collected and analyzed data acquired from a single institute at which robot-assisted laparoscopic radical prostatectomy was performed. A total of 174 patients underwent radical prostatectomy, and the collected data included age, PSA level, body weight, BMI, and pathology results.

RESULTS

A total of 174 patients were diagnosed with adenocarcinoma of the prostate by needle biopsy, and most (N = 165) were considered to have localized disease on preoperative multiparameter magnetic resonance imaging. After prostatectomy, 73% (N = 127) of the patients remained in the localized disease group (group A) and 27% (N = 47) of the patients were reclassified to the locally advanced prostate cancer (group B). The value of PSA was higher in group B (16.9 vs 11.2 ng/dL; p = 0.062), but there was no statistically significant difference between the two groups. After using the numerical values of PSA × body weight and PSA × BMI, a statistically significant difference emerged between the two groups ( p = 0.0198 in PSA × BW; p = 0.0110 in PSA × BMI).

CONCLUSION

The body mass-weighted PSA levels, instead of the traditional PSA concentration, may be better markers for predicting non-organ-confined disease after surgery. It may also be useful in screening and risk categorization.

Для цитирования: Ou Ying-Lun, Yang Ming-Hsin, Kao Chien-Chang, Meng En, Chen Jin-Li, Tsao Chih-Wei, Sun Guang-Huan, Yu Dah-Shyong, Cha Tai-Lung, Wu Sheng-Tang. Body mass weighted prostate-specific antigen levels, new markers to predict locally advanced prostate cancer after prostatectomy.. Journal of the Chinese Medical Association : JCMA. 2024. DOI: 10.1097/jcma.0000000000001109.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.